Ledger.Open graph →
SEC Form D · filed March 25, 2024

Alpenglow Biosciences, Inc

Offering
$4.8M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jonathan T. Liu · Seattle, WADirectorMichael T. Dutton · Seattle, WAExecNicholas P. Reder · Seattle, WAExec · DirectorDaniella T. Kranjac · Seattle, WADirectorDaniella T. Kranjac · Seattle, WADirectorJonathan T. Liu · Seattle, WADirectorMichael T. Dutton · Seattle, WAExecNicholas P. Reder · Seattle, WAExec · DirectorAlex T. Springer · Seattle, WAExecJames Watt · Houston, TXDirectorWilliam Robertson · Houston, TXExecGregg Williams · Bozeman, MTDirectorNicolas De Castro · BOZEMAN, MTExec · DirectorAlex T. Springer · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗